{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:03:02Z","timestamp":1768582982257,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.radonc.2016.05.021","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T22:47:16Z","timestamp":1466981236000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site"],"prefix":"10.1016","volume":"120","author":[{"given":"Peter","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myo","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dion","family":"Forstner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Chicco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.05.021_b0005","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"Wei","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.05.021_b0010","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2967\/jnumed.108.053660","article-title":"PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study","volume":"49","author":"Scott","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2016.05.021_b0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0020","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0025","first-page":"37","article-title":"Emerging treatment options for nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2013","journal-title":"Drug Design Develop Ther"},{"key":"10.1016\/j.radonc.2016.05.021_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","article-title":"Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients","volume":"64","author":"Baujat","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.05.021_b0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2014.05.005","article-title":"Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study","volume":"112","author":"Wu","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.radonc.2012.08.001","article-title":"The battle against nasopharyngeal cancer","volume":"104","author":"Lee","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0045","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2002.07.011","article-title":"Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation","volume":"20","author":"Rischin","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0050","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2001.19.5.1350","article-title":"Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"19","author":"Ma","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2015.07.030","article-title":"Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: meta-analysis of randomised controlled trials","volume":"116","author":"Chen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.radonc.2012.09.001","article-title":"Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?","volume":"104","author":"Guo","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2013.10.007","article-title":"Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy","volume":"110","author":"Tang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.radonc.2010.04.006","article-title":"Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break","volume":"96","author":"Xu","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/MNM.0b013e3283495662","article-title":"Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification","volume":"32","author":"Chan","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.radonc.2016.05.021_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2967\/jnumed.111.090696","article-title":"Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma","volume":"53","author":"Chang","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2016.05.021_b0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2008.01.009","article-title":"Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas","volume":"87","author":"Lee","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0090","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/annonc\/mdp430","article-title":"Prognostic value of 18F-FDG PET\/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma","volume":"21","author":"Xie","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0095","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00432-009-0729-7","article-title":"Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma","volume":"136","author":"Xie","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13014-014-0268-5","article-title":"Pretreatment 18 inverted question mark F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma inverted question mark inverted question mark a retrospective study","volume":"10","author":"Yang","year":"2015","journal-title":"Radiat Oncol (London, England)"},{"key":"10.1016\/j.radonc.2016.05.021_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2015.06.025","article-title":"Predicting the need for adaptive radiotherapy in head and neck cancer","volume":"116","author":"Brown","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2012.03.013","article-title":"A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients","volume":"104","author":"Cheng","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2015.05.018","article-title":"Identifying patients who may benefit from adaptive radiotherapy: does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help?","volume":"115","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.05.021_b0120","article-title":"Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma","volume":"1\u201311","author":"Min","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2016.05.021_b0125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis","volume":"55","author":"Pak","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016311240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016311240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T19:53:16Z","timestamp":1536609196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016311240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0167814016311240"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.05.021","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}